Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOEBT1 who wrote (2768)	5/14/1999 4:56:00 PM
From: Biomaven	Read Replies (1) of 10280

JOEBT1: I think each ICE stands on its own - if there was some problem w/ nori (which is by no means certain yet) this doesn't translate into doubts about the other ICEs (except to the extent it goes to SEPR's credibility). For any particular ICE there has always been a chance that the efficacy gain will not be significant or that some toxicity issue will show up. Remember we don't know the royalty rate that SEPR will have to pay J&J now - if it is fairly high (like 15%), then J&J may well have just made a strategic decision to stay out of respiratory and sit back and let someone else do the work, even though the drug is still in good shape. They certainly don't have much of a franchise to defend. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next